Considering the $11B Gilead paid for Pharmasset, Benitec has to be worth significantly more than $1B when we receive good phase II data!
If we even get wind of cracking Hepatitis C wide open… bring on $10 per share! Stranger things have happened!
Add to My Watchlist
What is My Watchlist?